Skip to main content
. 2021 May 31;7(6):442. doi: 10.3390/jof7060442

Table 3.

Characteristics of patients according to the final outcome (survival).

Survivors
N = 66
Non-Survivors
N = 43
Difference (95% CI)
Age (years) * 29.8 46.0 16.2 (5.8–26.6)
Age > 60 years (%) 15.2 37.2 22.0 (5.2–38.9)
Previous length of stay (days) 19.7 28.4 8.8 (0.3–17.2)
Shock (%) 15.2 34.9 19.7 (3.1–36.4)
Apache (points) ** 12.1 15.3 3.2 (−13.2–6.5)
Cancer (%) 12.1 34.9 22.8 (6.5–39.0)
Abdominal surgery (%) 24.2 41.9 17.6 (−0.4–35.6)
Persistent candidemia (%) 19.7 9.3 10.4 (−2.5–23.3)
Catheter removal (%) 24.2 2.3 21.9 (10.6–33.2)
Early treatment (%) 30.3 16.3 14.0 (−1.6–29.7)
No treatment (%) 12.2 30.2 18.0 (2.3–33.9)
Fluconazole as initial treatment(%) 60.6 41.9 18.7 (−0.1–37.6)

* Mean, ** Data available for 90 patients (55 survivors and 35 non-survivors).